MSF Malaria Project in Cambodia
Our projects in Cambodia are currently focused on tackling hepatitis C and malaria.

We launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country.

Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.

The team started by screening HIV patients at the hospital for co-infection. In October, screening was expanded to include patients referred by the hospital’s hepatology department.

Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.

In 2018
 
Training session for COVID-19 in Cambodia
Coronavirus disease COVID-19

Preparing for COVID-19 in South-East Asia

Interview 5 Mar 2020
 
MSF has started an intervention for the outbreak of COVID-19
Coronavirus disease COVID-19

Supporting preparedness efforts to fend off coronavirus

Voices from the Field 14 Feb 2020
 
Hepatitis C active case finding
Cambodia

Affordable drugs and new hepatitis C treatment method save lives

Project Update 24 Jul 2019
 
Tondo project in Philippines
Photo Story

A year in pictures 2017

18 Dec 2017
Photo Story
 
Hepatitis C - Clinic Cambodia
Photo Story

Treating hepatitis C in Phnom Penh

21 Aug 2017
Photo Story
 
Journal article

Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study

27 Oct 2014
Journal article